Anlon Healthcare

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01025
  • NSEID: AHCL
  • BSEID: 544497
INR
13.20
0.08 (0.61%)
BSENSE

May 06

BSE+NSE Vol: 13.83 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 80.65% vs -41.01% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 108.32% vs 24.54% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -5.48% vs 3.50% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 112.46% vs 65.93% in Mar 2024

Compare Profit and Loss Results of Anlon Healthcare
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
120.00
407.00
-287.00
-70.52%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
120.00
407.00
-287.00
-70.52%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-2.00
5.00
250.00%
Raw Materials Consumed
71.00
197.00
-126.00
-63.96%
Power & Fuel Cost
2.00
11.00
-9.00
-81.82%
Employee Cost
4.00
57.00
-53.00
-92.98%
Operating Expenses
2.00
24.00
-22.00
-91.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
24.00
-23.00
-95.83%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
2.00
-1.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
88.00
333.00
-245.00
-73.57%
Operating Profit (PBDIT) excl Other Income
32.00
74.00
-42.00
-56.76%
Other Income
0.00
20.00
-20.00
-100.00%
Operating Profit (PBDIT)
32.00
94.00
-62.00
-65.96%
Interest
3.00
10.00
-7.00
-70.00%
Profit before Depriciation and Tax
28.00
83.00
-55.00
-66.27%
Depreciation
1.00
12.00
-11.00
-91.67%
Profit Before Taxation & Exceptional Items
26.00
70.00
-44.00
-62.86%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
26.00
70.00
-44.00
-62.86%
Provision for Tax
6.00
23.00
-17.00
-73.91%
Profit After Tax
20.00
47.00
-27.00
-57.45%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2.00
145.00
-143.00
-98.62%
Profit Available for appropriations
22.00
193.00
-171.00
-88.60%
Appropriations
22.00
193.00
-171.00
-88.60%
Equity Dividend (%)
0%
10%
-10.00
Earnings Per Share
6.37
1.41
4.96
351.77%
Profit And Loss - Net Sales
Net Sales 120.29 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 80.65% vs -41.01% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.21 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 108.32% vs 24.54% in Mar 2024

Profit And Loss - Interest
Interest 3.72 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.48% vs 3.50% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 20.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 112.46% vs 65.93% in Mar 2024